Streetbeat News

Products Services

WIX

Wix has informed Benzinga that partners can start earning revenue share immediately when using Wix Studio, enhancing the financial benefits of the Wix Partner Program.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 4:50 pm

WIX

Wix has informed Benzinga of a transformation in its revenue sharing model for partners, which is expected to substantially increase their earning opportunities on the Wix platform.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 4:50 pm

ACRS

Aclaris Therapeutics Inc (NASDAQ:ACRS) reported mixed results from its Phase 2b study of ATI-1777 for atopic dermatitis. The study met its primary efficacy endpoint with statistical significance for the 2% twice-daily dosage compared to the vehicle. However, the once-daily dosage showed a trend toward significance but was not statistically superior. Post-hoc analysis indicated a significant reduction in EASI score for moderate to severe cases. The drug was well tolerated with minimal exposure levels and no significant safety issues. ACRS shares dropped 22.5% to $0.99 following the news.

Portfolio Pulse from Vandana Singh

January 10, 2024 | 4:39 pm

ABBV

An AbbVie executive has projected a return to market growth for Botox in Q3 and continued momentum in Q4, despite the launch of competing products. The company also plans to pursue early-stage opportunities, which are expected to be smaller in size.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 4:38 pm

PLTR

Shares of Palantir Technologies Inc. (NYSE:PLTR) are rising after CEO Alex Karp reported increased demand for new tools from Israel amid the conflict with Hamas. Karp, in Tel Aviv for Palantir's first board meeting there, met with Israel's President and families of hostages. Despite internal resistance, Karp reaffirmed support for Israel. PLTR shares are up 3.63% to $16.99.

Portfolio Pulse from Nabaparna Bhattacharya

January 10, 2024 | 4:18 pm

BNTX

WuXi Biologics has signed a research service agreement with BioNTech to discover monoclonal antibodies for developing therapeutic product candidates. WuXi Biologics will receive a $20M upfront payment and may get additional payments for milestones and royalties. The collaboration leverages WuXi's proprietary antibody discovery platforms to support BioNTech's pipeline.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 4:16 pm

ATOM

Atomera Inc (NASDAQ:ATOM) has updated its Q4 revenue guidance to approximately $500,000, up from the previous range of $300,000 to $350,000. This comes after achieving a revenue milestone with a customer validating MST film deposition on an Epi tool. The company's stock is trading higher by 9.9% at $7.27 following the news.

Portfolio Pulse from Adam Eckert

January 10, 2024 | 4:13 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo for January 10th, 2024, provides trade strategies for SPY, QQQ, AAPL, MSFT, META, TSLA, GOOGL, and NVDA based on a proprietary formula considering price, volume, and options flow. The memo outlines potential bullish and bearish price targets for each asset and advises traders to stay alert for breakouts or reversals. The session's focus is on Wholesale Inventories and Trade Sales data, with anticipation for CPI data the following day. The memo is part of a service offered by Market Clubhouse, which includes daily market analysis, a watch list, and real-time trading mentorship by a pro trader known as RIPS.

Portfolio Pulse from RIPS

January 10, 2024 | 4:03 pm

BB

BlackBerry has introduced the QNX Everywhere initiative, aimed at providing easy access to QNX software for academia, advanced research organizations, and hobbyists. This initiative is designed to facilitate skills development in these groups.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 4:01 pm

BB

VicOne and BlackBerry have partnered to enhance cybersecurity for automotive OEMs and fleet operators by using machine-learning at the edge and cloud-controlled vehicle data access. This collaboration aims to streamline the process of identifying cyberattacks, distinguishing them from non-malicious events more efficiently.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 3:40 pm